Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 20, 2024MedCommOpen Access

Targeting CD300ld to normalize the tumor microenvironment: an emerging insight in cancer immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

LZLin‐Zhu ZhangXHXu HeHZHai‐Dong Zhu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhang et al. (2024) studied this question.

synapsesocial.com/papers/68e63f56b6db6435875d093bhttps://doi.org/10.1002/mco2.607
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy2024
  2. 2CD300e as a Driver of Immunosuppressive Tumor Microenvironment in Colorectal Cancer2024
  3. 3CD300e is a driver of the immunosuppressive tumor microenvironment and colorectal cancer progression via macrophage reprogramming2025 · 2 citations
  4. 4CD300ld blockade overcomes PMN-MDSC-mediated vaccine resistance in advanced tumors2026
  5. 5CD300a as a Potential Immune Checkpoint in Breast Cancer: Insights from in vivo and in vitro Models.2026